Pacira price target lowered to $68 from $71 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Pacira to $68 from $71 and keeps a Buy rating on the shares. The analyst believes expectations heading into the company’s Q2 results are “very low,” below sell-side consensus estimates, based on weak third-party data sales estimates through May. The stock is near a bottom and already reflects an expected Q2 miss, while indications support a back-half of 2023 improvement, the analyst tells investors in a research note.